Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Webinar: Current and Future Management Strategies of Patients with Oesophageal Cancer

Aired live on 15 Mar 2022

ESMO-Webinar-Management-Strategies-Webinar-1000x250

ESMO Webinar: Current and Future Management Strategies of Patients with Oesophageal Cancer

Chair: Andrés Cervantes
Speakers: Radka Obermannova, Ian Chau and Sarah Derks

Learning objectives

  • To understand the best standard approach for patients with localised oesophageal cancer
  • To select the optimal sequence of Immune Checkpoint Inhibitors when treating advanced oesophageal cancer
  • To properly use different predictive biomarkers to get the maximum benefit of Immune Checkpoint Inhibitors

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.